As Albany lawmakers consider imposing costly new taxes and mandates on health insurance, a report from the New York State Health Foundation offers a timely reminder: The state’s insurance premiums are already among the highest in the country, and rising fast.
Due to recent changes in the federal tax code, the already exorbitant cost of single-payer for New York taxpayers has gotten even steeper.
Reforms that would reduce the state’s cost burdens and improve its climate for growth.
A bill requiring health plans to cover digital breast tomosynthesis, a three-dimensional type of mammography, has been delivered to Governor Andrew Cuomo’s office for his signature or veto. If the measure is enacted into law, it would be a classic case of healthcare politics rushing ahead of medical science.
If President Trump follows through on a threat to halt Obamacare’s “cost-sharing reduction” program, New York has more to lose than almost any other state.
Washington lawmakers are contemplating fallback healthcare legislation that risks repeating one of Albany’s most notorious policy blunders – and triggering a “death spiral” in non-group insurance markets nationwide.
The makers of the anti-addiction drug Vivitrol – whose controversial nationwide lobbying campaign was spotlighted by the New York Times last week – appear to be getting results in Albany.
The House GOP is a model of cautious deliberation next to the Assembly’s handling of the New York Health Act, which would establish a statewide single-payer plan.